Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cormedix Inc (NQ: CRMD )

5.650 +0.550 (+10.78%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,106,656
Open 5.150
Bid (Size) 5.450 (10)
Ask (Size) 5.680 (2)
Prev. Close 5.100
Today's Range 5.100 - 5.738
52wk Range 2.570 - 7.000
Shares Outstanding 38,086,437
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CorMedix (CRMD) Q2 2024 Earnings Call Transcript
CRMD earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
CRMD Stock Earnings: Cormedix Meets EPS, Misses Revenue for Q2 2024
CRMD stock results show that Cormedix met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
+49.87%
+49.87%
1 Month
+18.45%
+18.45%
3 Month
+10.35%
+10.35%
6 Month
+72.26%
+72.26%
1 Year
+40.20%
+40.20%

More News

Read More
Trading SMID Biotech Stocks In A Volatile Market
Via Talk Markets
CRMD Stock Earnings: Cormedix Beats EPS for Q1 2024
Via InvestorPlace
CorMedix (CRMD) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
Via InvestorPlace
Cormedix Earnings Preview
Via Benzinga
Why CorMedix Stock Popped Wednesday
Via Benzinga
CorMedix Inc. (NASDAQ: CRMD) Leading the Way in Wednesday Trading Based on Percentage Gain
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
CorMedix (CRMD) Q4 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Earnings Scheduled For March 12, 2024
Via Benzinga
The Latest Analyst Ratings for Cormedix
Via Benzinga
CorMedix (CRMD) Q2 2023 Earnings Call Transcript
Via The Motley Fool
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Target Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
CorMedix (CRMD) Q3 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
CorMedix's DefenCath Aims to Tackle Catheter-Related Blood Stream Infections: Analyst
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
Via Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.